China Cardiovascular Devices Market Outlook to 2016

GlobalData, September 2010, Pages: 327

China Cardiovascular Devices Market Outlook to 2016

Summary

Our medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides key market data on the China cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices. This medical equipment report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Market size and company share data for seven cardiovascular devices market categories - Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices.
- Annualized market revenues (USD million), volume (units) and average price ($) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the China cardiovascular devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical Inc., Cordis Corporation., Abbott Laboratories, Terumo Corporation and C.R. Bard, Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China cardiovascular devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Cardiovascular Devices In China
3.1 Cardiovascular Devices, China, Overall Revenue ($m), 2002-2016
3.2 Cardiovascular Devices Market, China, Revenue Mix ($m), 2009
3.3 Cardiovascular Devices Market, China, Category Contribution (%), 2009
3.4 Cardiovascular Devices, China, Category Volume (Units), 2002-2016
3.5 Cardiovascular Devices, China, Company Share (2008-2009)
4 Cardiac Assist Devices In China
4.1 Cardiac Assist Devices, Market Segmentation
4.2 Cardiac Assist Devices Market, China, Revenue Mix ($m), 2009
4.3 Cardiac Assist Devices Market, China, Segment Contribution (%), 2009
4.4 Cardiac Assist Devices Overall Revenue (2002-2016)
4.4.1 Intra-Aortic Balloon Pump Revenue (2002-2016)
4.4.2 Ventricular Assist Devices Revenue (2002-2016)
4.5 Cardiac Assist Devices Overall Volume (2002-2016)
4.5.1 Intra-Aortic Balloon Pump Volume (2002-2016)
4.5.2 Ventricular Assist Devices Volume (2002-2016)
4.6 Cardiac Assist Devices Average Price (2002-2016)
4.7 Cardiac Assist Devices Distribution Share (2008-2009)
4.8 Cardiac Assist Devices, China, Company Share (2008-2009)
5 Cardiac Rhythm Management In China
5.1 Cardiac Rhythm Management, Market Segmentation
5.2 Cardiac Rhythm Management Market, China, Revenue Mix ($m), 2009
5.3 Cardiac Rhythm Management Market, China, Segment Contribution (%), 2009
5.4 Cardiac Rhythm Management Overall Revenue (2002-2016)
5.4.1 Cardiac Resynchronisation Therapy Revenue (2002-2016)
5.4.2 Implantable Cardioverter Defibrillator Revenue (2002-2016)
5.4.3 Pacemaker Revenue (2002-2016)
5.5 Cardiac Rhythm Management Overall Volume (2002-2016)
5.5.1 Cardiac Resynchronisation Therapy Volume (2002-2016)
5.5.2 Implantable Cardioverter Defibrillator Volume (2002-2016)
5.5.3 Pacemaker Volume (2002-2016)
5.6 Cardiac Rhythm Management Average Price (2002-2016)
5.7 Cardiac Rhythm Management Distribution Share (2008-2009)
5.8 Cardiac Rhythm Management, China, Company Share (2008-2009)
6 Cardiovascular Monitoring and Diagnostic Devices In China
6.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation
6.2 Cardiovascular Monitoring and Diagnostic Devices Market, China, Revenue Mix ($m), 2009
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, China, Segment Contribution (%), 2009
6.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2002-2016)
6.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2002-2016)
6.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2002-2016)
6.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2008-2009)
6.8 Cardiovascular Monitoring and Diagnostic Devices, China, Company Share (2008-2009)
7 Cardiovascular Prosthetic Devices In China
7.1 Cardiovascular Prosthetic Devices, Market Segmentation
7.2 Cardiovascular Prosthetic Devices Market, China, Revenue Mix ($m), 2009
7.3 Cardiovascular Prosthetic Devices Market, China, Segment Contribution (%), 2009
7.4 Cardiovascular Prosthetic Devices Overall Revenue (2002-2016)
7.4.1 Septal Occluder Revenue (2002-2016)
7.5 Cardiovascular Prosthetic Devices Overall Volume (2002-2016)
7.5.1 Septal Occluder Volume (2002-2016)
7.6 Cardiovascular Prosthetic Devices Average Price (2002-2016)
7.7 Cardiovascular Prosthetic Devices Distribution Share (2008-2009)
7.8 Cardiovascular Prosthetic Devices, China, Company Share (2008-2009)
8 Cardiovascular Surgery In China
8.1 Cardiovascular Surgery, Market Segmentation
8.2 Cardiovascular Surgery Market, China, Revenue Mix ($m), 2009
8.3 Cardiovascular Surgery Market, China, Segment (%), 2009
8.4 Cardiovascular Surgery Overall Revenue (2002-2016)
8.4.1 Perfusion Disposables Revenue (2002-2016)
8.5 Cardiovascular Surgery Overall Volume (2002-2016)
8.5.1 Perfusion Disposables Volume (2002-2016)
8.6 Cardiovascular Surgery Average Price (2002-2016)
8.7 Cardiovascular Surgery Distribution Share (2008-2009)
8.8 Cardiovascular Surgery, China, Company Share (2008-2009)
9 Electrophysiology In China
9.1 Electrophysiology, Market Segmentation
9.2 Electrophysiology Market, China, Revenue Mix ($m), 2009
9.3 Electrophysiology Market, China, Segment (%), 2009
9.4 Electrophysiology Overall Revenue (2002-2016)
9.5 Electrophysiology Overall Volume (2002-2016)
9.6 Electrophysiology Average Price (2002-2016)
9.7 Electrophysiology Distribution Share (2008-2009)
9.8 Electrophysiology, China, Company Share (2008-2009)
10 External Defibrillator In China
10.1 External Defibrillator, Market Segmentation
10.2 External Defibrillator, China, Revenue Mix ($m), 2009
10.3 External Defibrillator Market, China, Segment Contribution (%), 2009
10.4 External Defibrillator Overall Revenue (2002-2016)
10.5 External Defibrillator Overall Volume (2002-2016)
10.6 External Defibrillator Average Price (2002-2016)
10.7 External Defibrillator Distribution Share (2008-2009)
10.8 External Defibrillator, China, Company Share (2008-2009)
11 Interventional Cardiology In China
11.1 Interventional Cardiology, Market Segmentation
11.2 Interventional Cardiology Market, China, Revenue Mix ($m), 2009
11.3 Interventional Cardiology Market, China, Segment Contribution (%), 2009
11.4 Interventional Cardiology Overall Revenue (2002-2016)
11.4.1 Cardiac Catheter Revenue (2002-2016)
11.4.2 Coronary Stent Revenue (2002-2016)
11.4.3 PTCA Balloon Revenue (2002-2016)
11.4.4 Intravascular Ultrasound System (IVUS) Revenue (2002-2016)
11.5 Interventional Cardiology Overall Volume (2002-2016)
11.5.1 Cardiac Catheter Volume (2002-2016)
11.5.2 Coronary Stent Volume (2002-2016)
11.5.3 PTCA Balloon Volume (2002-2016)
11.5.4 Intravascular Ultrasound System (IVUS) Volume (Units)
11.6 Interventional Cardiology Average Price (2002-2016)
11.7 Interventional Cardiology Distribution Share (2008-2009)
11.8 Interventional Cardiology, China, Company Share (2008-2009)
12 Peripheral Vascular Devices In China
12.1 Peripheral Vascular Devices, Market Segmentation
12.2 Peripheral Vascular Devices Market, China, Revenue Mix ($m), 2009
12.3 Peripheral Vascular Devices Market, China, Segment Contribution (%), 2009
12.4 Peripheral Vascular Devices Overall Revenue (2002-2016)
12.4.1 Peripheral Vascular Stent Revenue (2002-2016)
12.5 Peripheral Vascular Devices Overall Volume (2002-2016)
12.5.1 Peripheral Vascular Stent Volume (2002-2016)
12.6 Peripheral Vascular Devices Average Price (2002-2016)
12.7 Peripheral Vascular Devices Distribution Share (2008-2009)
12.8 Peripheral Vascular Devices, China, Company Share (2008-2009)
13 Prosthetic Heart Valve In China
13.1 Prosthetic Heart Valve, Market Segmentation
13.2 Prosthetic Heart Valve Market, China, Revenue Mix ($m), 2009
13.3 Prosthetic Heart Valve Market, China, Segment Contribution (%), 2009
13.4 Prosthetic Heart Valve Overall Revenue (2002-2016)
13.4.1 Mechanical Heart Valve Revenue (2002-2016)
13.4.2 Tissue Heart Valve Revenue (2002-2016)
13.5 Prosthetic Heart Valve Overall Volume (2002-2016)
13.5.1 Mechanical Heart Valve Volume (2002-2016)
13.5.2 Tissue Heart Valve Volume (2002-2016)
13.6 Prosthetic Heart Valve Average Price (2002-2016)
13.7 Prosthetic Heart Valve Distribution Share (2008-2009)
13.8 Prosthetic Heart Valve, China, Company Share (2008-2009)
14 Overview of Key Companies in China Cardiovascular Devices Market
14.1 MicroPort Medical (Shanghai) Co. Ltd.
14.1.1 Company Overview
14.1.2 Share in the China Cardiovascular Devices Market
14.2 Medtronic, Inc.
14.2.1 Company Overview
14.2.2 Share in the China Cardiovascular Devices Market
14.3 Boston Scientific Corporation
14.3.1 Company Overview
14.3.2 Share in the China Cardiovascular Devices Market
14.4 Lepu Medical Technology (Beijing) Co., Ltd.
14.4.1 Company Overview
14.4.2 Share in the China Cardiovascular Devices Market
14.5 JW Medical Systems Limited
14.5.1 Company Overview
14.5.2 Share in the China Cardiovascular Devices Market
14.6 Terumo Corporation
14.6.1 Company Overview
14.6.2 Share in the China Cardiovascular Devices Market
14.7 Cordis Corporation
14.7.1 Company Overview
14.8 St. Jude Medical, Inc.
14.8.1 Company Overview
14.9 Abbott Laboratories
14.9.1 Company Overview
14.10 Sorin S.p.A.
14.10.1 Company Overview
14.11 Edwards Lifesciences Corporation
14.11.1 Company Overview
14.12 Biosense Webster, Inc.
14.12.1 Company Overview
14.13 C. R. Bard, Inc.
14.13.1 Company Overview
14.14 ZOLL Medical Corporation
14.14.1 Company Overview
14.15 Thoratec Corporation
14.15.1 Company Overview
14.16 GE Healthcare
14.16.1 Company Overview
14.17 Philips Healthcare
14.17.1 Company Overview
14.18 Welch Allyn Inc.
14.18.1 Company Overview
14.19 Nihon Kohden Corporation
14.19.1 Company Overview
14.20 Fukuda Denshi Co., Ltd.
14.20.1 Company Overview
14.21 Teleflex Incorporated
14.21.1 Company Overview
14.22 OSI Systems, Inc.
14.22.1 Company Overview
14.23 BIOTRONIK SE & Co. KG
14.23.1 Company Overview
14.24 Schiller AG
14.24.1 Company Overview
14.25 ABIOMED, Inc.
14.25.1 Company Overview
14.26 Cardiac Science Corporation
14.26.1 Company Overview
14.27 MAQUET GmbH & Co. KG
14.27.1 Company Overview
14.28 Volcano Corporation
14.28.1 Company Overview
14.29 AGA Medical Holdings, Inc.
14.29.1 Company Overview
14.30 Cook Medical Incorporated
14.30.1 Company Overview
14.31 W. L. Gore & Associates, Inc.
14.31.1 Company Overview
14.32 ev3 Inc.
14.32.1 Company Overview
14.33 SynCardia Systems, Inc.
14.33.1 Company Overview
15 Cardiovascular Devices Market Pipeline Products
15.1 Interventional Cardiology Market Pipeline Products
15.1.1 Coronary Stent Market Pipeline Products
15.1.2 PTCA Balloon Market Pipeline Products
15.1.3 Cardiac Catheter Market Pipeline Products
15.1.4 Coronary Guidewire Market Pipeline Products
15.1.5 Arteriotomy Closure Devices Market Pipeline Products
15.2 Cardiac Rhythm Management Market Pipeline Products
15.2.1 Pacemaker Market Pipeline Products
15.3 Peripheral Vascular Devices Market Pipeline Products
15.3.1 Peripheral Vascular Stent Market Pipeline Products
15.3.2 Aortic Stent Graft Market Pipeline Products
15.3.3 Synthetic Surgical Grafts Market Pipeline Products
15.3.4 Peripheral Guidewire Market Pipeline Products
15.3.5 Embolic Protection Device Market Pipeline Products
15.4 Electrophysiology Market Pipeline Products
15.4.1 Electrophysiology Ablation Catheter Market Pipeline Products
15.4.2 Electrophysiology Lab Systems Market Pipeline Products
15.5 Cardiovascular Surgery Market Pipeline Products
15.5.1 Cardiac Ablation Devices Market Pipeline Products
15.6 Prosthetic Heart Valve Market Pipeline Products
15.6.1 Tissue Heart Valve Market Pipeline Products
15.6.2 Mechanical Heart Valve Market Pipeline Products
15.7 Cardiac Assist Devices Market Pipeline Products
15.7.1 Ventricular Assist Devices Market Pipeline Products
15.8 Cardiovascular Prosthetic Devices Market Pipeline Products
15.8.1 Cardiac Valve Repair Market Pipeline Products
15.9 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products
15.9.1 ECG Monitoring Equipment Market Pipeline Products
16 Recent Developments
16.1 Strategy And Business Planning
16.1.1 Aug 08, 2010: Medtronic Opens Patient Care Center In Beijing, China
16.2 Government and Public Interest
16.2.1 Jun 28, 2010: BioOhio To Collaborate With Beijing On Bioscience Growth
16.3 Product News
16.3.1 Aug 02, 2010: CardioMag Imaging Receives Two Patents In US, China
16.3.2 Mar 26, 2010: Risk Of Cardiovascular Disease More Likely Due To Aortic Pulse Wave Velocity
17 Appendix
17.1 Definitions of Markets Covered in the Report
17.1.1 Cardiovascular Devices
17.2 Research Methodology
17.3 Secondary Research
17.4 Primary Research
17.5 Models
17.6 Forecasts
17.7 Expert Panels
17.8 Consulting
17.9 Currency Conversion
17.10 Contact Us
17.11 Disclaimer

MicroPort Medical (Shanghai) Co. Ltd.
Medtronic, Inc.
Boston Scientific Corporation
Lepu Medical Technology (Beijing) Co., Ltd.
JW Medical Systems Limited
Terumo Corporation
Cordis Corporation
St. Jude Medical, Inc.
Abbott Laboratories
Sorin S.p.A.
Edwards Lifesciences Corporation
Biosense Webster, Inc.
C. R. Bard, Inc.
ZOLL Medical Corporation
Thoratec Corporation
GE Healthcare
Philips Healthcare
Welch Allyn Inc.
Nihon Kohden Corporation
Fukuda Denshi Co., Ltd.
Teleflex Incorporated
OSI Systems, Inc.
BIOTRONIK SE & Co. KG
Schiller AG
ABIOMED, Inc.
Cardiac Science Corporation
MAQUET GmbH & Co. KG
Volcano Corporation
AGA Medical Holdings, Inc.
Cook Medical Incorporated
W. L. Gore & Associates, Inc.
ev3 Inc.
SynCardia Systems, Inc.

Customers who bought this item also bought

• Global Cardiovascular Monitoring & Diagnostic Devices Market (2011 - 2016)
• Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
• China Wellness Industry Outlook 2016 - Potential Opportunities in Tier-2 and Tier-3 Cities in China
• China Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
• China Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
• Asia-Pacific Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
• China Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• Nephrology and Urology Devices Market Outlook in China to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others
• Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections